$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA. Insider overview, share value development, latest insider transactions and email notifications about new events in VERTEX PHARMACEUTICALS INC / MA for free.

CIK Number: 0000875320
IRS Number: 043039129
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VRTX
Company Address: 50 NORTHERN AVENUE BOSTON 02210
Phone number: (617) 444-6100

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Market Capitalization: $21.78B
Prev close: $86.84
Average Daily Volume: 1,946,100
Days Low: $85.79
Year Low: $71.46
Year High: $103.73

VERTEX PHARMACEUTICALS INC / MA Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
ALTSHULER DAVIDEVP, Global Research and CSO39,1133,396,573shares bought: 139,124 / shares sold: -152,921 SELLNov 19 201824 days ago
Arbuckle Stuart AEVP\Chief Commercial Officer46,7524,059,944shares bought: 323,204 / shares sold: -389,952 SELLNov 19 201824 days ago
Bhatia Sangeeta N.Director6,997607,619shares bought: 31,574 / shares sold: -26,695 BUYOct 05 20182 months ago
Graney ThomasChief Financial Officer12,4301,079,421shares bought: 14,066 / shares sold: -1,076 STRONG BUYOct 02 20182 months ago
Kewalramani ReshmaEVP and CMO1,909165,778shares bought: 0 / shares sold: -2,305 STRONG SELLOct 09 20182 months ago
Parini MichaelEVP, CL&AO39,6093,439,646shares bought: 86,654 / shares sold: -48,884 STRONG BUYNov 19 201824 days ago
Sachdev AmitEVP, CRO46,6624,052,128shares bought: 286,667 / shares sold: -315,130 SELLNov 19 201824 days ago
SACHS BRUCE IDirector23,0111,998,275shares bought: 16,930 / shares sold: -5,129 STRONG BUYDec 07 20186 days ago
Silva Paul MSVP & Corp Controller16,8961,467,249shares bought: 112,629 / shares sold: -109,789 BUYDec 04 20189 days ago

View all VERTEX PHARMACEUTICALS INC / MA insiders.

VERTEX PHARMACEUTICALS INC / MA Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 07 2018VRTXVERTEX PHARMACEUTI ...SACHS BRUCE IDirectorOption ExerciseM34.2410,000342,4000
Dec 07 2018VRTXVERTEX PHARMACEUTI ...SACHS BRUCE IDirectorBuyM34.2410,000342,40023,01113 K to 23 K (+76.86 %)
Dec 04 2018VRTXVERTEX PHARMACEUTI ...Silva Paul MSVP & Corp Controll ...Option ExerciseM86.5280969,9957,281
Dec 04 2018VRTXVERTEX PHARMACEUTI ...Silva Paul MSVP & Corp Controll ...SellS186.52809150,89516,08716.9 K to 16.1 K (-4.79 %)
Dec 04 2018VRTXVERTEX PHARMACEUTI ...Silva Paul MSVP & Corp Controll ...BuyM86.5280969,99516,89616.1 K to 16.9 K (+5.03 %)
Nov 19 2018VRTXVERTEX PHARMACEUTI ...Silva Paul MSVP & Corp Controll ...SellS163.75121,96516,08716.1 K to 16.1 K (-0.07 %)
Nov 19 2018VRTXVERTEX PHARMACEUTI ...Parini MichaelEVP, CL&AOSellS163.759014,73839,60939.7 K to 39.6 K (-0.23 %)
Nov 19 2018VRTXVERTEX PHARMACEUTI ...Sachdev AmitEVP, CROSellS163.75619,98946,66246.7 K to 46.7 K (-0.13 %)
Nov 19 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS163.75294,74946,75246.8 K to 46.8 K (-0.06 %)
Nov 19 2018VRTXVERTEX PHARMACEUTI ...ALTSHULER DAVIDEVP, Global Researc ...SellS163.7510016,37539,11339.2 K to 39.1 K (-0.26 %)
Nov 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...Option ExerciseM131.892,125280,2666,375
Nov 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...SellS179.002,125380,37546,75248.9 K to 46.8 K (-4.35 %)
Nov 08 2018VRTXVERTEX PHARMACEUTI ...Arbuckle Stuart AEVP\Chief Commercia ...BuyM131.892,125280,26648,87746.8 K to 48.9 K (+4.55 %)
Nov 08 2018VRTXVERTEX PHARMACEUTI ...ALTSHULER DAVIDEVP, Global Researc ...Option ExerciseM131.892,125280,2666,375
Nov 08 2018VRTXVERTEX PHARMACEUTI ...ALTSHULER DAVIDEVP, Global Researc ...SellS181.892,125386,51639,11341.2 K to 39.1 K (-5.15 %)

View all VERTEX PHARMACEUTICALS INC / MA insider transactions.